- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypercholesterolaemia
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 542KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 108KB)
Evolocumab – March 2024
Evolocumab: Injection 140 mg in 1 mL single use pre filled pen, Injection 420 mg in 3.5 mL single use pre filled cartridge; Repatha®
Last updated
30 May 2025